Trinity Capital Inc. Expands Life Sciences Vertical with Appointment of Paul D'Agrosa

Rhea-AI Summary

Trinity Capital (Nasdaq: TRIN) appointed Paul D'Agrosa as Managing Director of Life Sciences, based in Denver, effective Oct. 8, 2025.

Mr. D'Agrosa joins to help expand Trinity's Life Sciences platform across new U.S. markets; he brings more than a decade of experience in loan origination, business development, and relationship management. His prior roles include Managing Director at Horizon Technology Finance, where he helped originate more than $140 million in new loan commitments within his first 15 months, and 10 years at Silicon Valley Bank in relationship and credit roles.

The company framed the hire as a step to strengthen life‑sciences lending and source new opportunities across Medtech, Healthtech, Biotech, and Diagnostics/Tools.

Positive

• Appointment targets expansion of Life Sciences vertical across U.S. markets
• Over $140M in loan commitments originated by D'Agrosa at Horizon within 15 months
• Adds 10+ years of sector experience including Silicon Valley Bank roles
• New Denver base broadens Trinity's geographic coverage in the Western U.S.

Negative

• None.

PHOENIX, Oct. 8, 2025 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading alternative asset manager, today announced the appointment of Paul D'Agrosa as Managing Director of Life Sciences, based in Denver, Colorado. Mr. D'Agrosa will help expand the Company's Life Sciences business to new markets across the U.S., bringing with him more than a decade of experience in loan origination, business development, and relationship management.

"We are pleased to welcome Paul to the team," said Rob Lake, Senior Managing Director of Life Sciences at Trinity Capital. "His track record in life sciences lending and network of industry relationships will play an important role as we strengthen and grow our Life Sciences platform."

Prior to Trinity, Mr. D'Agrosa served as Managing Director at Horizon Technology Finance, where he oversaw the Western U.S. Healthcare and Life Sciences market. At Horizon, he assisted in originating more than $140 million in new loan commitments within his first 15 months, with a focus on verticals of Medtech, Healthtech, Biotech, and Diagnostics/Tools. Previously, Mr. D'Agrosa spent 10 years at Silicon Valley Bank, where he held multiple positions, including SVP Relationship Manager and Credit Solutions Vice President.

"I'm excited to join Trinty and originate new opportunities for the team," said Mr. D'Agrosa. "Trinity is growing rapidly, and I look forward to helping them support innovative companies that are transforming the industry."

About Trinity Capital Inc.
Trinity Capital Inc. (Nasdaq: TRIN) is an international alternative asset manager that seeks to deliver consistent returns for investors through access to private credit markets. Trinity Capital sources and structures investments in well-capitalized growth-oriented companies across five distinct lending verticals: Sponsor Finance, Equipment Finance, Tech Lending, Asset Based Lending, and Life Sciences. As a long-term, trusted partner for innovative companies seeking tailored debt solutions, Trinity Capital has deployed more than $4.7 billion across over 420 investments since inception in 2008 (As of June 30, 2025). Headquartered in Phoenix, Arizona, Trinity Capital's dedicated team is strategically located across the United States and Europe. For more information on Trinity Capital, please visit trinitycapital.com and stay connected to the latest activity via LinkedIn and X (@trincapital).

View original content to download multimedia:https://www.prnewswire.com/news-releases/trinity-capital-inc-expands-life-sciences-vertical-with-appointment-of-paul-dagrosa-302577669.html

SOURCE Trinity Capital Inc.

FAQ

Who is Paul D'Agrosa and what role did Trinity Capital (TRIN) name him to on Oct. 8, 2025?

Trinity named Paul D'Agrosa Managing Director of Life Sciences, based in Denver, to expand its life‑sciences lending platform.

What experience does Paul D'Agrosa bring to Trinity Capital (TRIN)?

He brings 10+ years in banking and credit roles, including time at Silicon Valley Bank and as Managing Director at Horizon Technology Finance.

How much lending did Paul D'Agrosa originate at Horizon before joining TRIN?

He assisted in originating more than $140 million in new loan commitments within his first 15 months at Horizon.

How will the hire affect Trinity Capital's (TRIN) Life Sciences coverage?

The hire is intended to expand Life Sciences business into new U.S. markets and strengthen sourcing in Medtech, Healthtech, Biotech, and Diagnostics/Tools.

Where will Paul D'Agrosa be based for Trinity Capital (TRIN) and why does location matter?

He will be based in Denver, Colorado, which broadens Trinity's geographic coverage in the Western U.S.

Does the announcement state any immediate financial guidance or capital commitments for TRIN related to the hire?

No. The announcement describes the strategic hire and past originations but does not state new guidance or capital commitments.